Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients

Journal of Biomedical Science

Volumn 11, Issue 1, 2004, Pages 117-126

  Wu, Ho Sheng ^a,b,c   Hsieh, Yueh Chun ^c   Su, Ih Jen ^b   Lin, Ting Hsiang ^b   Chiu, Shu Chun ^b   Hsu, Yu Fen ^b   Lin, Jih Hui ^b   Wang, Mei Ching ^b   Chen, Jeou Yuan ^d   Hsiao, Pei Wen ^e   Chang, Geen Dong ^f   Wang, Andrew H J ^c   Ting, Hsien Wei ^c   Chou, Chih Ming ^g   Huang, Chang Jen ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antibody response; Recombinant proteins; SARS CoV infection; Western blotting

Indexed keywords

ENVELOPE PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NUCLEOCAPSID PROTEIN; RECOMBINANT PROTEIN; STRUCTURAL PROTEIN; VITRONECTIN;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARS VIRUS; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; TIME FACTORS; VIRAL STRUCTURAL PROTEINS;

CORONAVIRUS; ESCHERICHIA COLI;

EID: 0842343388     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000075294     Document Type: Article

References (18)

1. Büttner J. Evaluation of the diagnostic value of laboratory investigations. J Clin Chem Clin Biochem 15:1-12;1977.
2. CDC SARS Investigative Team, Fleischauer AT. Outbreak of severe acute respiratory syndrome - worldwide, 2003. Mor Mortal Wkly Rep 52:226-228;2003.
3. Cumulative number of SARS probable cases in Taiwan, SARS Online Information Center, Center for Disease Control, Taiwan [Accessed July 2, 2003]. Available from: URL: http://www.cdc.gov.tw/sarsen.
4. de Arriba ML, Carvajal A, Pozo J, Rubio P. Mucosal and systemic isotype-specific antibody responses and protection in conventional pigs exposed to virulent or attenuated porcine epidemic diarrhoea virus. Vet Immunol Immunopathol 85:85-97;2002.
5. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348:1967-1976;2003.
6. Elia G, Fiermonte G, Pratelli A, Martella V, Camero M, Cirone F, Buonavoglia C. Recombinant M protein-based ELISA test for detection of antibodies to canine coronavirus. J Virol Methods 109:139-142;2003.
7. Krokhin O, Li Y, Andonov A, Feldman H, Flick R, Jones S, Stroeher U, Bastien N, Dasuri KV, Cheng K, et al. Mass spectrometric characterization of proteins from the SARS virus: A preliminary report. Mol Cell Proteomics 2:346-356;2003.
8. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348:1953-966;2003.
9. Lee ML, Chen CJ, Su IJ, Chen KT, Yeh CC, King CC, Chang HL, Wu YC, Ho MS, Jiang DD, et al. Severe acute respiratory syndrome - Taiwan, 2003. Morb Mortal Wkly Rep 52:461-466;2003.
10. Loa CC, Lin TL, Wu CC, Bryan T, Hooper T, Schrader D. Specific mucosal IgA immunity in turkey poults infected with turkey coronavirus. Vet Immunol Immunopathol 88:57-64;2002.
11. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA, Chan SY, et al. The Genome sequence of the SARS-associated coronavirus. Science 300:1399-1404;2003.
12. Naslund K, Traven M, Larsson B, Silvan A, Linde N. Capture ELISA systems for the detection of bovine coronavirus-specific IgA and IgM antibodies in milk and serum. Vet Microbiol 72:183-206;2002.
13. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet 361:1767-1772;2003.
14. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-325;2003.
15. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399;2003.
16. Twu SJ, Chen TJ, Chen CJ, Olsen SJ, Lee LT, Fisk T, Hsu KH, Chang SC, Chen KT, Chiang IH, et al. Control measures for severe Acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis 9:718-720;2003.
17. Use of laboratory methods for SARS diagnosis, WHO 2003 [Accessed July 2, 2003]. Available from: URL: http://www.who.int/csr/sars/lab-methods/en/print. html.
18. van Ginkel FW, Nguyen HH, McGhee JR. Vaccines for mucosal immunity to combat emerging infectious diseases. Emerg Infect Dis 6:123-132;2000.